Olsson Gunnar L, Meyerson Björn A, Linderoth Bengt
Pain Treatment Unit, Astrid Lindgren Children's Hospital, 17176, Stockholm, Sweden.
Eur J Pain. 2008 Jan;12(1):53-9. doi: 10.1016/j.ejpain.2007.02.007. Epub 2007 Sep 21.
Complex regional pain syndrome type I (CRPS-I) is not uncommon in children, particularly in adolescent girls. Most often, the condition involves a foot and is characterized by spontaneous pain, tactile allodynia and dysautonomic signs. There is usually a history of a minor, local trauma but sometimes no reasonable cause can be identified, and there are no signs of persistent tissue injury giving rise to ongoing nociception. Common analgesics are generally of no benefit, and the standard treatment includes sociopsychological support, physiotherapy, tricyclic antidepressants and antiepileptic drugs, sympathetic blocks (SB), and cognitive-behavioural therapy. For a minority of patients who prove to be resistant to such therapies, spinal cord stimulation (SCS) may be tried. The present study comprises seven girls, 11-14 years of age, presenting with severe, incapacitating and therapy-resistant CRPS-I, who were subjected to SCS. In two of them, percutaneous electrode implantation had to be performed in general anaesthesia. Trial stimulation was performed in all, but one. In two cases, it was not possible to produce paraesthesias that entirely covered the pain area. A pain relieving effect of SCS was usually not reported until after 1-2 weeks of trial stimulation. After another 2-6 weeks, pain alleviation was complete in five of the seven patients, one to eight years after the intervention. In one case, a local infection necessitated the removal of the electrode; nevertheless a few days of trial stimulation produced substantial pain relief that still persists. In four patients, the SCS use was gradually diminished and eventually the device could be removed. The favourable outcome in all seven cases with no or minor remaining symptoms and without severe recurrences illustrates that SCS may also be an efficient treatment in paediatric cases with exceptionally therapy resistant forms of CRPS I.
I型复杂性区域疼痛综合征(CRPS-I)在儿童中并不罕见,尤其是在青春期女孩中。最常见的情况是累及足部,其特征为自发痛、触诱发痛和自主神经功能障碍体征。通常有轻微局部创伤史,但有时找不到合理原因,也没有持续组织损伤导致持续伤害性感受的迹象。常用镇痛药一般无效,标准治疗包括社会心理支持、物理治疗、三环类抗抑郁药和抗癫痫药物、交感神经阻滞(SB)以及认知行为疗法。对于少数被证明对这些疗法耐药的患者,可以尝试脊髓刺激(SCS)。本研究包括7名11至14岁的女孩,她们患有严重且致残的耐药性CRPS-I,并接受了SCS治疗。其中两人需要在全身麻醉下进行经皮电极植入。除一人外,所有人都进行了试验刺激。在两例中,无法产生完全覆盖疼痛区域的感觉异常。通常在试验刺激1至2周后才报告SCS的止痛效果。再过2至6周,7名患者中有5名在干预1至8年后疼痛完全缓解。在一例中,局部感染需要取出电极;尽管如此,几天的试验刺激仍产生了持续的显著疼痛缓解。在4例患者中,SCS的使用逐渐减少,最终可以取出装置。所有7例患者均取得良好效果,无或仅有轻微残留症状,且无严重复发,这表明SCS对于具有特殊耐药形式的小儿CRPS I病例可能也是一种有效的治疗方法。